La sécurité des patients est un principe fondamental des soins de santé. Plusieurs pays à revenu élevé ont publié des études montrant que les soins de santé causent des préjudices à un grand nombre de patients, et que ces préjudices peuvent entraîner des séquelles durables, des durées... d’hospitalisation plus longues, voire la mort
more
This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatrelvir-ritonavir for non-severe COVID-19.
Les manuels de formation TACT et la brochure destinée aux patients ont été élaborés dans le cadre de l'initiative du consortium ACT visant à améliorer la prise en charge du paludisme en encourageant l'utilisation correcte des tests de diagnostic rapide (TDR). L'initiative TACT (Targeting ACTs...) vise à garantir l'utilisation appropriée des combinaisons thérapeutiques à base d'artémisinine (ACT), en ne traitant que les cas de paludisme confirmés et en orientant les patients vers d'autres traitements pour les maladies fébriles non liées au paludisme. Les manuels proposent une formation interactive sur le lieu de travail pour aider les personnels de santé à passer d'un traitement présomptif à un diagnostic fondé sur des tests, conformément à la politique de l'OMS. La brochure d'accompagnement destinée aux patients, disponible en anglais et en swahili, s'appuie sur des récits illustrés pour expliquer l'utilité et le fonctionnement des TDR, répondre aux inquiétudes les plus courantes et encourager la confiance dans les résultats des tests. Ces documents, dont la clarté et la compréhension ont été testées au préalable, permettent d'opérer des changements durables dans la pratique clinique et la communication avec les patients au sein des établissements de soins primaires tanzaniens.
Accessed on 03/07/2025.
more
MSD Manual Patient information
No one should be harmed in healthcare. And yet, at least five people die every minute of patient safety failures in low and middle income countries alone. We can all do something to save these lives. Join us, commit to Patient Safety. Speak up for Patient Safety
Asthma is a chronic lung condition that affects your airways or bronchial tubes. It causes your airways to narrow, swell and produce extra mucus, which in turn makes it more difficult to breathe. The narrowing of the airways causes you to feel short of breath, wheezy or trigger fits of coughing.
Bebildertes Arzt-Patient-Gespräch in 25 Sprachen mit Symptomen, Diagnostik und Procedere.
Illustrated doctor-patient-interview in 25 languages containing symptoms, diagnosis and procedures. For Health Care Professionals.
Grundsprache Deutsch:Albanisch, Amharisch, Arabisch, Bulgarisch, Chinesis...ch, Englisch, Farsi, Französisch, Griechisch, Italienisch, Kurdisch, Niederländisch, Pashtu, Polnisch, Rumänisch, Russisch, Schwedisch, Serbisch, Somali, Spanisch, Tigrinya, Tschechisch, Türkisch, Urdu, Vietnamesisch
more
This Checklist is to minimize healthcare provider exposure when operating on COVID+ or suspected patient.
Communicating effectively allows us to clearly mark risks and measure patient safety limits.
This website collects patient education material about cervical cancer and the prevention in several languages (chinese, english, khmer, vietnamese). https://ethnomed.org/patient-education/cancer/cervical-cancer
Accessed 4rd of November 2015
This website collects patient education material about breast cancer, biopsy, chemotherapy, radiation, lymph nodes, margins and surgery in several languages (Amharic, english, khmer, spanish, somali, tigrinya, vietnamese). https://ethnomed.org/patient-education/cancer/breast-cancer
Accessed 4rd ...of November 2015
more
This study was aimed to ascertain the clinical profile and management of patients with ischemic heart disease (IHD) and/or peripheral artery disease (PAD). In this observational and cross-sectional study developed in 80 hospitals throughout Spain, consecutive adults with stable IHD and/or PAD were i...ncluded. A total of 1089 patients were analyzed, of whom 65.3% had only IHD, 17.8% PAD and 16.9% both. A total of 80.6% were taking only one antiplatelet agent, and 18.2% were on dual antiplatelet therapy (mainly aspirin/clopidogrel). Almost all patients were taking ≥1 lipid lowering drug, mainly moderate-to-high intensity statins. IHD patients took ezetimibe more commonly than PAD (43.9% vs. 12.9%; p < 0.001). There were more patients with IHD that achieved blood pressure targets compared to PAD (<140/90 mmHg: 67.9% vs. 43.0%; p < 0.001; <130/80 mmHg: 34.1% vs. 15.7%; p < 0.001), LDL-cholesterol (<70 mg/dL: 53.1% vs. 41.5%; p = 0.033; <55 mg/dL: 26.5% vs. 16.0%; p = 0.025), and diabetes (HbA1c < 7%, with SGLT2i/GLP1-RA: 21.7% vs. 8.8%; p = 0.032). Modifications of antihypertensive agents and lipid-lowering therapy were performed in 69.0% and 82.3% of patients, respectively, without significant differences between groups. The use of SGLT2i/GLP1-RA was low. In conclusion, cardiovascular risk factors control remains poor among patients with IHD, PAD, or both. A higher use of combined therapy is warranted.
more
Guide pour les pays à faibles revenus.